GVR Report cover Guidewires Market Size, Share & Trends Report

Guidewires Market Size, Share & Trends Analysis Report By Product (Coronary Guidewires, Peripheral Guidewires, Urology Guidewires, Neurovascular Guidewires), By Region, And Segment Forecasts, 2023 - 2030

  • Report ID: 978-1-68038-243-3
  • Number of Pages: 110
  • Format: Electronic (PDF)
  • Historical Range: 2018 - 2021
  • Industry: Healthcare

Report Overview:

The global guidewires market size was estimated at USD 2.45 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 5.54% from 2023 to 2030. The growth of the guidewire industry can be attributed to an increase in urological disorders, Peripheral Artery Disease (PAD), and cardiovascular diseases. A growing number of minimally invasive surgeries and a rising geriatric population further drive the growth. For instance, WHO estimates that by 2030, 1 in 6 people worldwide would be 60 years of age or older. The same demographic will double by 2050. Moreover, diseases are far more common among older adults. These includecardiovascular disease, ischemic heart disease, vascular dementia, and multiple sclerosis, among others.

Canada guidewires Market size and growth rate, 2023 - 2030

Technological advancements are one of the key factors boosting the application of guidewire. The advanced guidewires can be customized for specific requirements and can be operated remotely. This leads to an increased success rate of the procedures, and thus the overall adoption rate for minimally invasive surgeries. The integration of these guidewires with imaging modalities and surgical robots has endless applications in modern surgical practices.

For instance, in June 2023, Teleflex Incorporated introduced the Wattson Temporary Pacing Guidewire, designed specifically for use during Balloon Aortic Valvuloplasty (BAV) and Transcatheter Aortic Valve Replacement (TAVR). This guidewire offers supporting valve delivery, dual functionality, and ventricular bipolar pacing. It aims to improve procedural efficiencies and reduce complications associated with traditional methods.

With its advanced engineering, the guidewire minimizes the risk of ventricular perforation and ensures confidence in rapid pacing. The introduction of such innovative technologies addresses unmet clinical needs and underscores the commitment to improving patient care and simplifying structural procedures. These advancements have contributed to the expansion of the guidewire medical industry by offering improved solutions and driving increased demand.

Product Insights

Based on product, the market is segmented into coronary, peripheral, urology, and neurovascular guidewires. The coronary guidewires segment dominated the market with a revenue share of 43.40% in 2022. This is attributed to the significant increase in demand for minimally invasive coronary surgery and the increasing prevalence of cardiovascular disease.

For instance, according to the FDA, in January 2023, heart disease is responsible for almost one in four deaths in the U.S. Moreover, according to the CDC, it was reported in May 2023 that approximately 25 million adults in the U.S. have total cholesterol levels above 240 mg/dL, which is considered high. High cholesterol and uncontrolled high blood pressure are both significant risk factors for cardiovascular disease, heart disease, stroke, and other detrimental conditions.

In addition, high blood pressure is among one of the heart disease leading causes of premature death on a global scale. For instance, as reported by the WHO in March 2023, it is estimated that around 1.28 billion adults between the ages of 30 and 79 worldwide are affected by hypertension. Throughout the projection period, the segment's dominance is anticipated to be aided by the introduction of new technologies.

The market for guidewires is growing due to favorable reimbursement rules for cardiovascular procedures. For instance, Teleflex got FDA approval in February 2022 for an additional indication for the use of specialized catheters and coronary guidewires in Chronic Total Occlusion Percutaneous Coronary Intervention (CTO PCI) procedures.

The neurovascular segment is projected to witness the fastest CAGR over the forecast period, owing to an elevated risk of neurovascular conditions that impact the cerebellum, spinal cord, and brain vascular system, including aneurysms, cavernoma, arteriovenous malformations, dural arteriovenous fistula, cerebral hemorrhage, and stroke.

The existence of vital blood vessels makes the treatment of such illnesses difficult. The segment is growing, however, as these devices are increasingly used in complex neurovascular minimally invasive procedures. For instance, in January 2021, Rapid Medical announced its Drivewire innovative guidewire, a neurovascular guidewire with a programmable distal end for more accurate navigation. It has been given FDA clearance and can change shape appropriately for more precise navigation.

Global guidewires Market share and size, 2022

The urology segment is expected to experience a significant CAGR over the forecast period. This growth can be attributed to several key factors. Firstly, there is an increasing prevalence of urological disorders such as urinary tract infections (UTIs), kidney stones, and ureteral stones. These conditions are causing significant discomfort and are becoming more common globally. For instance, kidney stones are among the most agonizing urological disorders in 2021, according to the Journal of Taibah University Medical Science.

Kidney stone disease has seen a rise in its prevalence, affecting a substantial percentage of the population in different regions, including North America, Europe, and Asia Pacific. Research has also shown that kidney stones are excruciating and have become increasingly prevalent worldwide. They not only cause severe pain but also increase the risk of chronic kidney disease and end-stage renal disease. This factor is anticipated to drive the expansion of the urology guidewires industry in the near future.

The preference for minimally invasive surgeries is also contributing to the growth of the urology segment. Patients and healthcare providers are increasingly opting for procedures that minimize invasiveness and promote faster recovery. This trend is driving the demand for urology guidewires, as they play a crucial role in guiding medical devices during these minimally invasive procedures.

Moreover, the rising geriatric population, particularly in countries like Japan, India, and China, is fueling the demand for urological treatments and interventions. As individuals age, they become more prone to urological disorders, such as benign prostatic hyperplasia and urinary tract disorders. These conditions require medical attention, leading to an increased need for urology guidewires and related products.

Regional Insights

North America dominated the market and accounted for 35.33% of global revenue in 2022. The growing preference for minimally invasive surgeries is driving regional demand. This is mainly attributed to the high prevalence of heart diseases and the rise in the number of coronary and peripheral interventions. Additionally, the presence of key players such as Abbott; Terumo Medical Corporation; B. Braun Melsungen AG; and Boston Scientific Corporation is also one of the indicators that depict its current huge market potential. The growing prevalence of cardiovascular diseases and rising preference for minimally invasive surgeries in the U.S. are the key drivers supporting the regional market's expansion.

guidewires Market Trends, by Region, 2023 - 2030

The Asia Pacific guidewires market is expected to grow at a high CAGR during the forecast period due to factors such as the increasing prevalence of chronic diseases, rising geriatric population, and increasing healthcare expenditure. Furthermore, investments in healthcare infrastructure, favorable government initiatives, and untapped opportunities in emerging countries like China and India also remain promising drivers of growth. Additionally, the market growth is also driven by a large geriatric population, high frequency of heart disease, and demand for advanced minimally invasive surgery techniques with faster results and higher accuracy.

Key Companies & Market Share Insights

The growth of the guidewire market is also propelled by ongoing advancements in technology and product innovation. Manufacturers are continuously improving guidewire design, making them more flexible, trackable, and maneuverable. These enhancements enable better navigation and access to challenging anatomical structures. These technological advancements and innovative solutions offer healthcare professionals more efficient and effective tools, driving market growth.

For instance, in May 2023, Artiria received approval from the U.S. FDA for its real-time, deflectable guidewire to treat strokes and related neurovascular and peripheral conditions more effectively and efficiently. Furthermore, in August 2022, the first-ever human trial of a sirolimus-coated balloon was launched by BD to expand the range of available therapies for peripheral artery disease. Some prominent players in the global guidewires market include:

  • Boston Scientific Corporation 

  • Medtronic

  • Cook

  • B. Braun

  • Terumo Medical Corporation

  • Abbott

  • Stryker

  • Teleflex Incorporated

  • BD

Guidewires Market Report Scope 

Report Attribute


Market size value in 2023

USD 2.58 billion

Revenue forecast in 2030

USD 3.7 billion

Growth rate

CAGR of 5.54% from 2023 to 2030

Base year for estimation


Historical data

2018 - 2021

Forecast period

2023 - 2030

Report updated

August 2023

Quantitative units

Revenue in USD million/billion, and CAGR from 2023 to 2030

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, trends

Segments covered

Product, region

Regional scope

North America; Europe; Asia Pacific; Latin America; MEA

Country scope

U.S.; Canada; UK; Germany; France; Italy; Spain; Denmark; Sweden; Norway; Japan; China; India; Australia; South Korea; Thailand; Brazil; Mexico; Argentina; South Africa; Saudi Arabia; UAE; Kuwait

Key companies profiled

Boston Scientific Corporation; Medtronic; Cook; B. Braun; Terumo Medical Corporation; Abbott; Stryker; Teleflex Incorporated; BD

Customization scope

Free report customization (equivalent up to 8 analysts’ working days) with purchase. Addition or alteration to country, regional & segment scope

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Global Guidewires Market Report Segmentation

This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global guidewires market report based on product, and region:

Global guidewires Market Report Segmentation

  • Product Outlook (Revenue, USD Million, 2018 - 2030)

    • Coronary Guidewires

    • Peripheral Guidewires

    • Urology Guidewires

    • Neurovascular Guidewires

  • Regional Outlook (Revenue, USD Million, 2018 - 2030)

    • North America

      • U.S.

      • Canada

    • Europe

      • UK

      • Germany

      • France

      • Italy

      • Spain

      • Denmark

      • Sweden

      • Norway

    • Asia Pacific

      • Japan

      • China

      • India

      • Australia

      • South Korea

      • Thailand

    • Latin America

      • Brazil

      • Mexico

      • Argentina

    • Middle East and Africa (MEA)

      • South Africa

      • Saudi Arabia

      • UAE

      • Kuwait

Frequently Asked Questions About This Report

gvr icn


gvr icn

This FREE sample includes data points, ranging from trend analyses to estimates and forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities. Contact us now

Certified Icon

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.